About us
Who we are
Governance
Staff
Vacancies
What we do
Members
EuropaBio Members
About Membership
How we work
Healthcare Biotechnology Council
Cell & Gene Therapies
Medicines For Rare Diseases And Children
Regulatory Efficiency
Biosimilars & Public Procurement
Data & Digital
Patient Bio-Forum
Industrial Biotechnology Council
Food, Feed & Nutrition
Circular Bioeconomy
National Associations Council
SME Platform
Biomanufacturing Platform
Activities
25 Years of Innovation
EFIB 2022
European Biotech Week
Events
Newsroom
News & Publications
Newsletter
Library
Become a member
✕
28/02/2023
28/02/2023
How do we live in a bioeconomy? EuropaBio at the Swedish EU Council Presidency conference
23/02/2023
23/02/2023
EuropaBio Response to Public Consultation on Horizon Europe – interim evaluation
17/02/2023
17/02/2023
Inter-association letter to raise our concern about the proposed definition of “natural polymers” in the REACH restriction of microplastics
16/03/2023
16/03/2023
Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future
EuropaBio is pleased to announce that Disc Medicine has joined as a corporate member.
07/03/2023
07/03/2023
Disc Medicine joins EuropaBio: life-changing medicines for patients with hematologic disorders
EuropaBio is pleased to announce that Disc Medicine has joined as a corporate member.
06/03/2023
06/03/2023
Can the Pharmaceutical Strategy Deliver for Europe?
03/03/2023
03/03/2023
For The Love of Science
On the occasion of the International Day of Women and Girls in Science
01/03/2023
01/03/2023
Vlad Olteanu new Healthcare Public Affairs Director at EuropaBio
28/02/2023
28/02/2023
How do we live in a bioeconomy? EuropaBio at the Swedish EU Council Presidency conference
EuropaBio Industrial Biotechnology Director Agnes Borg took part in the Swedish EU Council Bioeconomy conference. She presented on the importance of food as a key part of the bioeconomy
28/02/2023
28/02/2023
Helping Europe Deliver for Rare Disease Patients
24/02/2023
24/02/2023
“Life is like a box of chocolates, you never know what you’ll get”
17/02/2023
17/02/2023
Do your best and do not forget, there will always be a next time!
10/02/2023
10/02/2023
Leave no pathway unexplored
06/02/2023
06/02/2023
Delivering Europe’s ambitions in rare disease
13/12/2022
13/12/2022
EuropaBio Principles for Genetic Testing and Testing for Genetically-Driven Risk Factor
European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
08/12/2022
08/12/2022
‘Rare Disease Moonshot’ – Scaling-up public-private partnerships to accelerate research into world’s rarest diseases
European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
02/12/2022
02/12/2022
EuropaBio’s 2022 Patient BioForum addresses the challenges of patients with unmet medical needs and calls for multi-stakeholder approach
European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
25/11/2022
25/11/2022
The time to act is now! Biotechnology for global transformation
11/11/2022
11/11/2022
The Revision of the Orphan Medicines Regulation Is an Opportunity. Will Europe Seize it?
24/10/2022
24/10/2022
European Biotech Week 2022: Bringing Biotech to Local Communities
20/10/2022
20/10/2022
Ensuring the full potential of EHDS: Stakeholders’ recommendations on how to make the digital transformation a success across Europe
19/10/2022
19/10/2022
#EFIB2022: Industrial biotechnology community comes together in Vilnius next week
06/10/2022
06/10/2022
EuropaBio celebrates its inaugural Healthcare BioForum
Load more
Become a member